Zhaoke Ophthalmology’s IND Application for Phase III Clinical Trial of NVK-002 for Myopia Treatment in China Accepted for Review by CDE
2021-07-16
Zhaoke Ophthalmology’s Last Patient Completed Treatment for Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease, New Drug Application Planned Around the End of 2021
2021-07-12
Podcast Series Episode 1: Myopia prevalence in children and adolescents and Zhaoke’s potential treatment solution
2021-07-05
Zhaoke Ophthalmology Participated in the 21st Chinese International Congress of Ophthalmology and Optometry and Glaucoma Academic Exchange Advisory Meeting
2021-06-28
Zhaoke Hong Kong and IACTA Entered Into License Agreement for IC-265 and IC-270
2021-05-05
Zhaoke Hong Kong and IACTA Entered Into License Agreement for IC-265 and IC-270
2021-05-05
Conclusion of Series B Fundraising of Approximately US$145 Million for Zhaoke Ophthalmology Marks Big Step Towards Achieving Possible Spin-off and Separate Listing
2021-05-05
Zhaoke Hong Kong and Nevakar Entered into an Exclusive Licensing Agreement for NVK-002
2021-05-05
Zhaoke Hong Kong and PanOptica Entered Into License Agreement for PAN-90806
2021-05-05